CNBX
Price:
$0.0004
Market Cap:
$37.01K
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids f...[Read more]
Industry
Biotechnology
IPO Date
2007-09-04
Stock Exchange
OTC
Ticker
CNBX
According to CNBX Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 8.89%. This represents a change of 300.41% compared to the average of 2.22% of the last 4 quarters.
The mean historical ROE of CNBX Pharmaceuticals Inc. over the last ten years is -28.26%. The current 8.89% ROE has changed -131.44% with respect to the historical average. Over the past ten years (40 quarters), CNBX's ROE was at its highest in in the February 2022 quarter at 269.59%. The ROE was at its lowest in in the November 2021 quarter at -210.86%.
Average
-28.26%
Median
10.13%
Minimum
-423.17%
Maximum
228.08%
Discovering the peaks and valleys of CNBX Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 116.93%
Maximum Annual ROE = 228.08%
Minimum Annual Increase = -5606.97%
Minimum Annual ROE = -423.17%
| Year | ROE | Change |
|---|---|---|
| 2025 | 12.58% | -55.12% |
| 2024 | 28.02% | -84.76% |
| 2023 | 183.91% | -19.37% |
| 2022 | 228.08% | -228.96% |
| 2021 | -176.86% | -58.21% |
| 2020 | -423.17% | -5606.97% |
| 2019 | 7.68% | -105.38% |
| 2018 | -142.76% | 116.93% |
| 2017 | -65.81% | -200.20% |
| 2016 | 65.68% | -62.44% |
The current ROE of CNBX Pharmaceuticals Inc. (CNBX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
74.84%
5-year avg
55.15%
10-year avg
-28.26%
CNBX Pharmaceuticals Inc.’s ROE is less than GeneLink, Inc. (147.34%), less than Endonovo Therapeutics, Inc. (9.10%), less than Microart Inc. (0%), greater than RVL Pharmaceuticals plc (-80.88%), less than Acura Pharmaceuticals, Inc. (30.77%), greater than Tian'an Pharmaceutical Co., Ltd. (-4.90%), less than Itoco Inc. (291.99%), greater than Filament Health Corp. (-198.47%), greater than Affymax, Inc. (-420.95%), less than Naturally Splendid Enterprises Ltd. (279.34%),
| Company | ROE | Market cap |
|---|---|---|
| 147.34% | $10.60K | |
| 9.10% | $31.88K | |
| 0% | $26.15K | |
| -80.88% | $3.14M | |
| 30.77% | $6.60K | |
| -4.90% | $51.78K | |
| 291.99% | $34.10K | |
| -198.47% | $26.18K | |
| -420.95% | $41.24K | |
| 279.34% | $881.66K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNBX Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CNBX Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CNBX Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for CNBX Pharmaceuticals Inc. (CNBX)?
What is the highest ROE for CNBX Pharmaceuticals Inc. (CNBX)?
What is the 3-year average ROE for CNBX Pharmaceuticals Inc. (CNBX)?
What is the 5-year average ROE for CNBX Pharmaceuticals Inc. (CNBX)?
How does the current ROE for CNBX Pharmaceuticals Inc. (CNBX) compare to its historical average?